586 related articles for article (PubMed ID: 35348849)
1. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment.
Seo J; Yun JE; Kim SJ; Chun YS
Pflugers Arch; 2022 Jun; 474(6):591-601. PubMed ID: 35348849
[TBL] [Abstract][Full Text] [Related]
2. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
Vaupel P; Schmidberger H; Mayer A
Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia and cancer cell metabolism.
Huang D; Li C; Zhang H
Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):214-9. PubMed ID: 24389642
[TBL] [Abstract][Full Text] [Related]
4. Revisiting the Warburg effect: historical dogma versus current understanding.
Vaupel P; Multhoff G
J Physiol; 2021 Mar; 599(6):1745-1757. PubMed ID: 33347611
[TBL] [Abstract][Full Text] [Related]
5. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.
Brahimi-Horn C; Pouysségur J
Bull Cancer; 2006 Aug; 93(8):E73-80. PubMed ID: 16935775
[TBL] [Abstract][Full Text] [Related]
6. PRKAR2B-HIF-1α loop promotes aerobic glycolysis and tumour growth in prostate cancer.
Xia L; Sun J; Xie S; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Sha J; Xue W
Cell Prolif; 2020 Nov; 53(11):e12918. PubMed ID: 33025691
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Hypoxia Dependent Reprogramming of Cancer Metabolism: Role of HIF-1 and Its Potential Therapeutic Implications in Leukemia.
Pandey S; Singh R; Habib N; Tripathi RM; Kushwaha R; Mahdi AA
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1121-1134. PubMed ID: 38679971
[TBL] [Abstract][Full Text] [Related]
8. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
[TBL] [Abstract][Full Text] [Related]
9. Autonomous glucose metabolic reprogramming of tumour cells under hypoxia: opportunities for targeted therapy.
Huang M; Yang L; Peng X; Wei S; Fan Q; Yang S; Li X; Li B; Jin H; Wu B; Liu J; Li H
J Exp Clin Cancer Res; 2020 Sep; 39(1):185. PubMed ID: 32928258
[TBL] [Abstract][Full Text] [Related]
10. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
[TBL] [Abstract][Full Text] [Related]
11. Cell metabolism under microenvironmental low oxygen tension levels in stemness, proliferation and pluripotency.
De Miguel MP; Alcaina Y; de la Maza DS; Lopez-Iglesias P
Curr Mol Med; 2015; 15(4):343-59. PubMed ID: 25941818
[TBL] [Abstract][Full Text] [Related]
12. The crosstalk between HIFs and mitochondrial dysfunctions in cancer development.
Bao X; Zhang J; Huang G; Yan J; Xu C; Dou Z; Sun C; Zhang H
Cell Death Dis; 2021 Feb; 12(2):215. PubMed ID: 33637686
[TBL] [Abstract][Full Text] [Related]
13. Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology.
Kierans SJ; Taylor CT
J Physiol; 2021 Jan; 599(1):23-37. PubMed ID: 33006160
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism.
Sharma A; Sinha S; Shrivastava N
Front Genet; 2022; 13():849040. PubMed ID: 35432450
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia and energetic tumour metabolism.
Brahimi-Horn MC; Bellot G; Pouysségur J
Curr Opin Genet Dev; 2011 Feb; 21(1):67-72. PubMed ID: 21074987
[TBL] [Abstract][Full Text] [Related]
16. Identification and Development of Cyclic Peptide Inhibitors of Hypoxia Inducible Factors 1 and 2 That Disrupt Hypoxia-Response Signaling in Cancer Cells.
Ball AT; Mohammed S; Doigneaux C; Gardner RM; Easton JW; Turner S; Essex JW; Pairaudeau G; Tavassoli A
J Am Chem Soc; 2024 Apr; 146(13):8877-8886. PubMed ID: 38503564
[TBL] [Abstract][Full Text] [Related]
17. Expression of AGPAT2, an enzyme involved in the glycerophospholipid/triacylglycerol biosynthesis pathway, is directly regulated by HIF-1 and promotes survival and etoposide resistance of cancer cells under hypoxia.
Triantafyllou EA; Georgatsou E; Mylonis I; Simos G; Paraskeva E
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1142-1152. PubMed ID: 29908837
[TBL] [Abstract][Full Text] [Related]
18. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
[TBL] [Abstract][Full Text] [Related]
19. HIF: a master regulator of nutrient availability and metabolic cross-talk in the tumor microenvironment.
Missiaen R; Lesner NP; Simon MC
EMBO J; 2023 Mar; 42(6):e112067. PubMed ID: 36808622
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer.
Huang Y; Chen Z; Lu T; Bi G; Li M; Liang J; Hu Z; Zheng Y; Yin J; Xi J; Lin Z; Zhan C; Jiang W; Wang Q; Tan L
J Exp Clin Cancer Res; 2021 Dec; 40(1):398. PubMed ID: 34930376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
